Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration

Clinical Infectious Diseases(2021)10.1093/cid/ciab448Source: DataRank Database

Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration is a research paper published in Clinical Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.21)OA: bronzeTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

F. Eun‐Hyung Lee ORCID,Lindsay Martin ORCID,Jennifer Shih ORCID,Mary Elizabeth Sexton ORCID,Merin Kuruvilla ORCID

Live enrichment

PubMed:33989390 PMC:PMC8194535 OpenAlex:https://openalex.org/W3160693971

National Institutes of Health

Grant: P01AI125180

National Institutes of Health

Grant: U01AI045969

National Institutes of Health

Grant: R01AI121252

National Institutes of Health

Grant: 5R01AI121252-04

Understanding Survival of Human Bone Marrow Long-Lived Plasma Cells

National Institutes of Health

Grant: 5P01AI125180-02

Plasma Cells in Health and Disease

National Institutes of Health

Grant: 5U01AI045969-07

Pathogenesis of RSV disease in the Elderly

Bill and Melinda Gates Foundation

Genentech

Bill and Melinda Gates Foundation

FWCI

1.21

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2025

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/cid/article-pdf/73/11/2108/41607595/ciab448.pdf

publisherhttps://academic.oup.com/cid/article-pdf/73/11/2108/41607595/ciab448.pdf

publisherhttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciab448/38830375/ciab448.pdf

journalhttps://doi.org/10.1093/cid/ciab448

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33989390

Fields of Study

Drug-Induced Adverse ReactionsFood Allergy and Anaphylaxis ResearchSARS-CoV-2 and COVID-19 Research03 medical and health sciences0302 clinical medicineCOVID-19COVID-19 VaccinesHumansSARS-CoV-2Vaccination HesitancymRNA Vaccines

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesmRNA VaccinesVaccination HesitancyHumans

Keywords

MedicineCoronavirusCoronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronaviridaeVirologySevere acute respiratory syndrome coronavirus2019-20 coronavirus outbreakRespiratory systemBetacoronavirusImmunologyDiseaseInfectious disease (medical specialty)Internal medicineOutbreakpolyethylene glycolGraded ChallengeVaccine AllergyCOVID-19 VaccinesSARS-CoV-2COVID-19HumansBrief ReportsmRNA VaccinesVaccination Hesitancy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being